All
Lilly to Acquire Novartis Animal Health
Eli Lilly will acquire Novartis Animal Health for approximately $5.4 billion.
Aastrom Biosciences Acquires Sanofi's Cell Therapy and Regenerative Medicine Business
Aastrom Biosciences will acquire Sanofi's CTRM business for $6.5 million.
Cubist Pharmaceuticals Issues Recall Due to Glass Particles in Vials
Cubist Pharmaceuticals issues voluntary nationwide recall of one lot of CUBICIN single use vials due to presence of particulate matter.
Roquette America and Quadra Ingredients Enter Partnership
Roquette America and Quadra Ingredients enter a partnership for the distribution of pharmaceutical products in Canada.
Hospira Issues Two Recalls Due to Visible Particulates
Hospira announces nationwide voluntary recall of propofol injectable emulsion, USP, and lidocaine HCI injection, USP due to visible particuluates.
Thomson Reuters Names Drugs to Watch in 2014
Thomson Reuters names three potential drugs anticipated to bring in over $1 billion in sales through 2019.
SI Group to Acquire Assets from Albemarle
SI Group agrees to purchase certain Albemarle assets and products.
Understanding the Cleaning Validation Lifecycle
The cleaning validation lifecycle includes assessment, development, validation, and monitoring.
BASF Builds New Plant in Germany
BASF builds a new plant for specialty amines in Ludwigshafen, Germany.
GSK Receives FDA Approval for Tanzeum
GSK receives FDA approval of Tanzeum for adults with type 2 diabetes.
AMRI Closes Facility in NY
AMRI will close its DDS facility in Syracuse, NY.
EMA Warns of Falsified Herceptin Vials
EMA notifies EU healthcare professionals of the falsified cancer drug Herceptin.
Mallinckrodt to Acquire Questcor Pharmaceuticals
Mallinckrodt will acquire Questcor to create a diversified, high-growth specialty pharmaceuticals company.
Metrohm Appoints New President and CEO
Metrohm appoints Edward Colihan as president and CEO of Metrohm USA.
EMA Sends Roche Findings to European Commission
EMA sends its results on Roche investigation of pharmacovigilance non-compliance to the European Commission.
PhRMA Report Reveals Growth Trajectories and Policy Factors Affecting Biopharmaceutical Growth
A new report from PhRMA outlines potential growth trajectories affecting the biopharmaceutical industry.
PolyTherics and MacroGenics Extend ADC Collaboration
ThioBridge linker technology to attach different payloads to a range of antibodies
PhRMA Appoints New Board Members
Ian Read, chairman and CEO of Pfizer, is elected chairman of the PhRMA.
Center for Biologics Evaluation and Research Relocates
CBER will move to the FDA White Oak campus in Silver Spring, Maryland.
Aesica Consortium Wins Technology Strategy Board Grant
Aesica's consortium project receives grant to investigate an industrial biotechnology process to improve the manufacturing of an API.
FDA Develops Alternative Assay to Increase Availability of Influenza Vaccines
FDA develops an assay that could speed the release of pandemic influenza vaccines.
Fette Compacting America Appoints New President
Fette Compacting America appoints Sean Scully as its new president.
Desktop Human Body Developed for Toxicity Testing
The Advanced Tissue-engineered Human Ectypal Network Analyzer project team is developing realistic human organs for testing.
Molecular Profiles Invests in Hot Melt Extrusion Technology
Molecular Profiles expands technology with GMP hot melt extrusion.
uniQure Announces Management Changes
uniQure appoints a new COO and vice president, Medical affairs.
Takeda, Lilly to Challenge $9 Billion Verdict in Diabetes Drug Case
Takeda Pharmaceuticals and Eli Lilly announced that they plan to challenge a $9 billion judgment in a lawsuit that alleged Actos caused a patient's bladder cancer.
ChemCon Passes its Fourth FDA Inspection
ChemCon passes its fourth FDA inspection in the 17-year history of the company.
A New Plant Biotech Approach for Efficient Production of Pharmaceutical Compound
European scientists have discovered a method to improve the efficiency of the pharmaceutical production through plant biotechnology.
Dalton Pharma Completes Aseptic Filling Capabilities Expansion
Dalton Pharma completes its $2.5 million expansion in Toronto for sterile and aseptic filling capabilities.
Sun Pharma to Acquire Ranbaxy
Sun Pharma acquisition of Ranbaxy Laboratories will create the fifth-largest specialty generics company in the world.
